The expression sites for variant surface glycoproteins of Trypanosoma brucei.

Piet Borst(The Netherlands Cancer Institute), Peter Holmes, Jeremy C. Mottram(Wellcome Centre for Molecular Parasitology), Geoff Hide(Newcastle upon Tyne Hospitals NHS Foundation Trust), Gloria Rudenko(Imperial College London), Richard McCulloch(Universidade de São Paulo), Wilbert Bitter(Vrije Universiteit Amsterdam), Fred van Leeuwen(Dutch Cancer Society), Mike Cross, Martin C. Taylor(London School of Hygiene & Tropical Medicine), Graham H. Coombs(University of Strathclyde), Patricia A. Blundell
Unknown
January 1, 1997
Cited by 22

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
The Genome Sequence of <i>Trypanosoma cruzi</i> , Etiologic Agent of Chagas Disease
|Science|2005|1.4k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Type VII secretion — mycobacteria show the way
|Nature Reviews Microbiology|2007|768